MedPath

Early and quick detection of pulmonary and extra pulmonary tuberculosis and resistance to one of the drugs used for treatment (rifampicin) using a real time PCR based assay (CB-NAAT)

Not Applicable
Conditions
Health Condition 1: null- Patients suspected of pulmonary and extra pulmonary tuberculosis and drug resistant tuberculosis
Registration Number
CTRI/2016/09/007329
Lead Sponsor
Father Muller Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients highly suspected of having pulmonary and extrapulmonary tuberculosis and drug resistant tuberculosis

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath